Ginsenoside Rh1 potentiates dexamethasone’s anti-inflammatory effects for chronic inflammatory disease by reversing dexamethasone-induced resistance
Arthritis Research & Therapy2014Vol. 16(3), pp. R106–R106
Citations Over TimeTop 19% of 2014 papers
Abstract
Rh1 could potentiate DEX's anti-inflammatory effects and does not cause a hyperglycemic side effect. Ginsenoside Rh1 combined with DEX may be a promising candidate treatment option for chronic inflammatory diseases in need of long-term immunosuppression therapies.
Related Papers
- → Reducing Reversing Vehicle Incidents in Australian Fleet Settings—A Case Study(2016)1 cited
- Analysis and Compare on Hydraulic Automatic Reversing Mechanisms(2008)
- → Using Options in Reversing Markets(2012)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- Reducing reversing vehicle incidents in Australian fleet settings: A case study(2016)